[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-182354-105":59,"doc-detail-182354-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-pharmacist-no-19-october-1988","THE PHARMACIST - No. 19 - October 1988","","A journal issue centered on the Chamber of Pharmacists’ trade union updates, featuring editorial content, government pharmaceutical services news, and professional governance details including council members. The contents cover meetings, department leadership, medical representation, cardiovascular advances, continuing education programming for 1988, and pharmacy developments in British community practice. It also includes bioethics dialogue, correspondence, viewpoints on syringe supply, and drug updates, reactions, and interactions, followed by a Malta pharmacy historical overview.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-pharmacist-no-19-october-1988/182354/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-pharmacist-no-19-october-1988/182354.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-08","2026-09-02",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What issue details and organization information are included?","Question",{"text":112,"@type":113},"The issue lists circulation information, editorial and correspondence contacts, advertising enquiry details, payment instructions, and the council membership structure for the Chamber of Pharmacists.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which professional and medical topics are featured in the contents?",{"text":117,"@type":113},"Featured topics include cardiovascular medicine advances, continuing education for 1988, important developments in British community pharmacy, bioethics dialogue, and medical representation activities.",{"name":119,"@type":110,"acceptedAnswer":120},"What types of drug information appear in the issue?",{"text":121,"@type":113},"The issue includes prescribing-style information for specific antibiotics and medication brands, plus sections on new drugs such as the recombinant DNA Hepatitis B vaccine and coverage of drug reactions and interactions.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},182354,1788348306,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":129,"read_time":144},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","ISIVWdVHd  \n61 ON886Ld380100SLSIV  HVHdO 38VHDa44 O euuno厂2019.10.15  \nAUGMENTIN  \nin treatment failure.  \nof the powerful B-lactamase inhibitor,clavulanic acid.and species within the scope of oral therapy  \n●AUGMENTIN-Broader in spectrumthan oral cephalosporins,co-trimoxazole,ampicilin,tetracycline or erythromycin.  \n●AUGMENTIN-Outstanding successagainst today's infections.PRESCRIBING INFORMATION  \n\n| Adut infections   | No.of  \u003Cbr>patient  \u003Cbr>assessed   | Clinically  \u003Cbr>cured/  \u003Cbr>improved   | Clinical  \u003Cbr>success   |\n| --- | --- | --- | --- |\n| Upper respiratory tract³   | 146   | 141   | 97%   |\n| Lower respiratory tract³   | 98   | 89   | 91%   |\n| Urinary tract³   | 175   | 167   | 95%   |\n| Skin&soft tisue⁴   | 81   | 75   | 93%   |\n|  |  |  |  |\n| Paediatric infections   | No.of  \u003Cbr>patients  \u003Cbr>assessed   | Clinically  \u003Cbr>cured  \u003Cbr>improved   | Clinical  \u003Cbr>success   |\n| Upper respiratory tracts56   | 70   | 70   | 100%   |\n| Lower respiratory tract?   | 28   | 27   | 96%   |\n| Urinary tract⁶78   | 61   | 57   | 93%   |\n\nINDICATIONS:Chest,ear,nose,throat,genito-urinary,skin and soft tissue(5mdre imesd Children9monthe²years25m  \ndosages may be doubled.Treatment should not be extended beyond 14 days(1)asthe urihyrate,(2)sthe potzsium shcONRAINDICATIONM:Penielinbperensiyity PECAUTIONS:EFECTS:Uncommon,mainly mild and uransitory,egdiartoea,indigestion,  \nACupan -Non narcotic analgesic  \nDorbanex -the gentle way to treat constipationDUromine -for the control of simple obesity  \nHiprex -an effective treatment for urinary tract infectionMedihaler Range-bronchodilators in aerosol form   Phoitex-a sustained release cough suppressant      Puimadil-a fast acting aerosol bronchodilator        \nNuelin S.A.-a long acting theophylline preparation for theroutine control of bronchospasm  \nRauWiloid -for the long-term management of hypertensionRikospray GPOup-a range of topical antiseptic aerosolproductsSupplamins -one-a-day multivitamin and mineral  \nFulldetails of these and other products are availablefrom...  \nJOSEPH CASSAR LIMITED  \n54 Melita Street  \nValletta,Malta  \nor direct from.                                        All product names;Riker;3M:trade marks  \nAMOXIL is a broad spectrum antibiotic suitable for a wide range of infections caused by susceptible organisms.  \nIndications  \nChildren:Oral and injectable-up to 2 years:62.5mg-125mg every8 hours.2-10 years:125mg-250mg every-8 hours.Based onbodyweight(including neonates)35-100mg/kg/day.Adults:Oral-250mg-500mg every 8 hours.Injectable-I.M.250-500mg every 8hours or more frequently if necessary.IV.500mg-2g every 4-6hours.(Doses in excess of 1g should be given by infusion over 30minutes).  \nPresentations  \nCapsules:maroon and gold capsules,each containing 250mg or500mg amoxycillin.  \nSyrup:125mg amoxycillin per 5ml in 60ml or 100ml bottles.Syrup Forte:250mg amoxycillin per 5ml in 60ml or 100ml bottles.Paediatric drops:125mg amoxycillin per 1.25ml in 10ml bottles withcalibrated dropper.  \nInjection:Vials containing 250mg or 500mg amoxycillin.  \nRespiratory,ENT,genito-urinary and skin and soft tissue infections.  \nDosage  \nPrescribing Information  \nPrecautions  \nReduced dosage is required in patients with impaired renal  \nfunction.  \nContra-indications  \nPenicillin hypersensitivity.  \nSide-effects  \nSide-effects,as with other penicillins,are usually of a mild and  \ntransitory nature;they may include diarrhoea,indigestion or an  \noccasional rash,which may be either urticarial or erythematous:in  \neither case it is advisable to discontnue treatment.  \nBencard  \nA Division of Beecham Pharmaceuticals,Brentford,England.Fullinformation is available on request from the company.AMOXIL and the Bencard logo are trademarks of BeechamPharmaceuticals,Brentford,England.  \nTHE PHARMACIST is publishedby the Chamber of Pharmacists,  \n1,Wilga Street,Paceville.It issent free to all Pharmacists anddistributed to doctors.Othersmay subscribe_at an annual sub-scription of Lm1.50 or obtaincopies","cbCaifk0iEGVjCMq","https://ap.wps.com/l/cbCaifk0iEGVjCMq","pdf",9574074,47,"English","# Editorial\n# The Government Pharmaceutical Services\n## News\n## Annual General Meeting\n## Reorganisation of the Government Pharmaceutical Services\n## The Head of Department of Pharmacy\n## Is a Pharmacist\n# Medical Representation\n## Recent Advances in Cardiovascular Medicine\n## Commonwealth Pharmacy Day\n## Continuing Education Programme 1988\n## Important Developments in British Community Pharmacy\n## National Dialogue on Bioethics\n# Letter to the Editor\n# Viewpoint\n## Sale and Supply of Syringes to Drug Abusers\n# New Drugs\n## Recombinant DNA Hepatitis B Vaccine\n# Drug Reactions and Interactions\n## Prof. P. F. D'Arcy\n# Pharmacy in Malta\n## From the Post War Period towards the Year 2000\n## Symposium and Pharmaceutical Exhibition\n## Tribute to Pharmacist Anthony M. Darmenia","[{\"question\":\"What issue details and organization information are included?\",\"answer\":\"The issue lists circulation information, editorial and correspondence contacts, advertising enquiry details, payment instructions, and the council membership structure for the Chamber of Pharmacists.\"},{\"question\":\"Which professional and medical topics are featured in the contents?\",\"answer\":\"Featured topics include cardiovascular medicine advances, continuing education for 1988, important developments in British community pharmacy, bioethics dialogue, and medical representation activities.\"},{\"question\":\"What types of drug information appear in the issue?\",\"answer\":\"The issue includes prescribing-style information for specific antibiotics and medication brands, plus sections on new drugs such as the recombinant DNA Hepatitis B vaccine and coverage of drug reactions and interactions.\"}]","THE PHARMACIST - No. 19 - October 1988 | PDF",118]